Crossmark

Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes

Published Online: 2023-02-27

Published Print: 2023-04

Authors

Palanca, Ana

Ampudia-Blasco, F. Javier http://orcid.org/0000-0003-0221-0901
Calderón, José Miguel

Sauri, Inmaculada

Martinez-Hervás, Sergio

Trillo, José Luis

Redón, Josep

Real, José T.
Funding

Funding for this research was provided by:

Novo Nordisk Pharma
License Information

Text and Data Mining valid from 2023-02-27

Version of Record valid from 2023-02-27
More Information

Article History

Received: 15 January 2023

Accepted: 8 February 2023

First Online: 27 February 2023

Document is current